Wen Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wen Li has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Liying Yao
3 shared publicationsCunling Zhang
2 shared publicationsDan Wu
Tianjin Institute of Obstetrics and Gynecology, Tianjin Central Hospital of Obstetrics and Gynecology, Tianjin, China
2 shared publications- Meiyi Xu
Tianjin Institute of Gynecology and Obstetrics, Tianjin Central Hospital of Gynecology and Obstetrics, Tianjin 300100, China
2 shared publications Shanshan Li
Tianjin Institute of Obstetrics and Gynecology, Tianjin Central Hospital of Obstetrics and Gynecology, Tianjin, China
2 shared publicationsYuling Guo
2 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in Journal of Diabetes Research
- Vol. 2026 (1)
Exploration of Early Biomarkers for Gestational Diabetes Mellitus in Pregnant Women Living Without Obesity
Background: Early prediction of gestational diabetes mellitus (GDM) enables timely interventions but remains challenging, particularly in women living without obesity who are often overlooked by standard screening methods. This exploratory analysis identifies early pregnancy biomarkers that show associations with GDM up to 8–12 weeks earlier than the established diagnostic timeframe. Methods: A retrospective nested case‐control study was conducted at Tianjin Central Hospital of Gynecology Obstetrics. After applying the predefined inclusion and exclusion criteria and removing cases with missing blood samples, a total of 136 women were included in the final analysis, comprising 56 women with GDM and 80 non‐GDM controls. These data were used to develop multiple machine learning models, including random forest, logistic regression, SVM, XGBoost, and KNN. The performance of these models was assessed by AUC, sensitivity, specificity, positive predictive value, and negative predictive value in an independent validation set. Results: The random forest classifier achieved the best performance with an AUC of 0.992 in the validation set, indicating excellent sensitivity and specificity. The model incorporated six measurable variables: age, BMI, and four cytokines (IL‐1 β , IL‐10, IL‐17A, and IL‐4) participating in immune regulation in pregnancy. Conclusions: GDM can be predicted with high accuracy early in pregnancy, even among women living without obesity. This study highlights the value of integrating immunological biomarkers with clinical characteristics and machine learning for proactive risk stratification. Although promising, our findings warrant validation in larger, multiethnic cohorts to ensure generalizability.
- 1 January 2026
- Published by Wiley in Journal of Diabetes Research
- Vol. 2026 (1)
Open AccessExploration of Early Biomarkers for Gestational Diabetes Mellitus in Pregnant Women Living Without Obesity
Background: Early prediction of gestational diabetes mellitus (GDM) enables timely interventions but remains challenging, particularly in women living without obesity who are often overlooked by standard screening methods. This exploratory analysis identifies early pregnancy biomarkers that show associations with GDM up to 8–12 weeks earlier than the established diagnostic timeframe. Methods: A retrospective nested case‐control study was conducted at Tianjin Central Hospital of Gynecology Obstetrics. After applying the predefined inclusion and exclusion criteria and removing cases with missing blood samples, a total of 136 women were included in the final analysis, comprising 56 women with GDM and 80 non‐GDM controls. These data were used to develop multiple machine learning models, including random forest, logistic regression, SVM, XGBoost, and KNN. The performance of these models was assessed by AUC, sensitivity, specificity, positive predictive value, and negative predictive value in an independent validation set. Results: The random forest classifier achieved the best performance with an AUC of 0.992 in the validation set, indicating excellent sensitivity and specificity. The model incorporated six measurable variables: age, BMI, and four cytokines (IL‐1 β , IL‐10, IL‐17A, and IL‐4) participating in immune regulation in pregnancy. Conclusions: GDM can be predicted with high accuracy early in pregnancy, even among women living without obesity. This study highlights the value of integrating immunological biomarkers with clinical characteristics and machine learning for proactive risk stratification. Although promising, our findings warrant validation in larger, multiethnic cohorts to ensure generalizability.
- Open Access
- 12 March 2025
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 16, 1463485
Prenatal diagnosis of intellectual disability, autosomal dominant 29 with a nonsense pathogenic variant in SETBP1: a case report and literature review
Introduction: Intellectual disability, autosomal dominant 29 is a rare disorder resulting from pathogenic variants of SETBP1 gene with no specific mutation hotspot identified. Systematic descriptions of new cases are crucial for understanding the genotypic and phenotypic spectrums of the disease.Case presentation: A pregnant woman was referred to the prenatal diagnosis center at our hospital because she has an intellectual disability and has previously given birth to a child with intellectual disabilities. Karyotype, CNV-seq and whole-exome sequencing (WES) were employed to investigate the potential genetic issues in the family. The SETBP1 NM_015559.2: c.2425C>T (p.Gln809*) nonsense variant was found in the proband and mother, who were diagnosed with MRD29. Amniocentesis and genetic analysis (CNV-seq and sanger sequencing for mutation site) were performed as fetal cortical abnormalities and subependymal cystic area presented by ultrasonic examination at 25 + 5 gestational weeks. The genetic analysis confirmed the SETBP1 c.2425C>T (p.Gln809*) nonsense mutation in the fetus. The parents terminated the pregnancy at 30 + 4 gestational weeks.Conclusion: The SETBP1 NM_015559.2: c.2425C>T (p.Gln809*) nonsense variant is pathogenic and SETBP1 haploinsufficiency may be associated with fatal cortical abnormalities. More prenatal clinical data is helpful for a better productive decision making and patient management.
- 12 March 2025
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 16, 1463485
Open AccessPrenatal diagnosis of intellectual disability, autosomal dominant 29 with a nonsense pathogenic variant in SETBP1: a case report and literature review
Introduction: Intellectual disability, autosomal dominant 29 is a rare disorder resulting from pathogenic variants of SETBP1 gene with no specific mutation hotspot identified. Systematic descriptions of new cases are crucial for understanding the genotypic and phenotypic spectrums of the disease.Case presentation: A pregnant woman was referred to the prenatal diagnosis center at our hospital because she has an intellectual disability and has previously given birth to a child with intellectual disabilities. Karyotype, CNV-seq and whole-exome sequencing (WES) were employed to investigate the potential genetic issues in the family. The SETBP1 NM_015559.2: c.2425C>T (p.Gln809*) nonsense variant was found in the proband and mother, who were diagnosed with MRD29. Amniocentesis and genetic analysis (CNV-seq and sanger sequencing for mutation site) were performed as fetal cortical abnormalities and subependymal cystic area presented by ultrasonic examination at 25 + 5 gestational weeks. The genetic analysis confirmed the SETBP1 c.2425C>T (p.Gln809*) nonsense mutation in the fetus. The parents terminated the pregnancy at 30 + 4 gestational weeks.Conclusion: The SETBP1 NM_015559.2: c.2425C>T (p.Gln809*) nonsense variant is pathogenic and SETBP1 haploinsufficiency may be associated with fatal cortical abnormalities. More prenatal clinical data is helpful for a better productive decision making and patient management.
- Open Access
- 1 January 2025
- Published by Wiley in Journal of Immunology Research
- Vol. 2025 (1) , 8405365
Th17/Treg Cell Imbalance May Contribute to Spontaneous Preterm Labor
Spontaneous preterm labor (SPTL) is a major cause of neonatal mortality and severe complications. T cells play a crucial role in mediating inflammation and immune tolerance at the maternal–fetal interface. T helper 17 cells (Th17, pro‐inflammatory) and regulatory T cells (Treg, anti‐inflammatory) are two subsets of CD4 + T cells with opposite functions, and their balance is important for maintaining immune homeostasis. Since infection and inflammation represent prominent factors responsible for the pathogenesis of SPTL, Th17/Treg imbalance at the maternal–fetal interface may trigger proinflammatory responses, potentially leading to SPTL. In this review, evidence from both clinical cases of SPTL and animal models indicates the presence of Th17/Treg imbalance in both peripheral blood and the maternal–fetal interface. Additionally, interleukin‐6 (IL‐6), interleukin‐1 β (IL‐1 β ), and interleukin‐8 (IL‐8) have been involved in the pathogenesis of inflammation‐induced SPTL, suggesting that Th17/Treg imbalance may have relevance to and be involved in the pathogenic process of SPTL. Moreover, the presence of Th17/Treg imbalance in risk factors for SPTL, such as autoimmune diseases and bacterial infections, further supports this connection indirectly. Although predictive models and interventional strategies related to SPTL have been explored, there is currently insufficient evidence to establish a direct causal relationship between Th17/Treg imbalance and the onset of SPTL.
- 1 January 2025
- Published by Wiley in Journal of Immunology Research
- Vol. 2025 (1) , 8405365
Open AccessTh17/Treg Cell Imbalance May Contribute to Spontaneous Preterm Labor
Spontaneous preterm labor (SPTL) is a major cause of neonatal mortality and severe complications. T cells play a crucial role in mediating inflammation and immune tolerance at the maternal–fetal interface. T helper 17 cells (Th17, pro‐inflammatory) and regulatory T cells (Treg, anti‐inflammatory) are two subsets of CD4 + T cells with opposite functions, and their balance is important for maintaining immune homeostasis. Since infection and inflammation represent prominent factors responsible for the pathogenesis of SPTL, Th17/Treg imbalance at the maternal–fetal interface may trigger proinflammatory responses, potentially leading to SPTL. In this review, evidence from both clinical cases of SPTL and animal models indicates the presence of Th17/Treg imbalance in both peripheral blood and the maternal–fetal interface. Additionally, interleukin‐6 (IL‐6), interleukin‐1 β (IL‐1 β ), and interleukin‐8 (IL‐8) have been involved in the pathogenesis of inflammation‐induced SPTL, suggesting that Th17/Treg imbalance may have relevance to and be involved in the pathogenic process of SPTL. Moreover, the presence of Th17/Treg imbalance in risk factors for SPTL, such as autoimmune diseases and bacterial infections, further supports this connection indirectly. Although predictive models and interventional strategies related to SPTL have been explored, there is currently insufficient evidence to establish a direct causal relationship between Th17/Treg imbalance and the onset of SPTL.